104 related articles for article (PubMed ID: 31345366)
21. Alzheimer's disease causation by copper toxicity and treatment with zinc.
Brewer GJ
Front Aging Neurosci; 2014; 6():92. PubMed ID: 24860501
[TBL] [Abstract][Full Text] [Related]
22. Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease.
Brewer GJ; Kaur S
Int J Alzheimers Dis; 2013; 2013():586365. PubMed ID: 24224111
[TBL] [Abstract][Full Text] [Related]
23. Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction.
Rembach A; Hare DJ; Lind M; Fowler CJ; Cherny RA; McLean C; Bush AI; Masters CL; Roberts BR
Int J Alzheimers Dis; 2013; 2013():623241. PubMed ID: 24228186
[TBL] [Abstract][Full Text] [Related]
24. Letter to the editor: Limitations of acetylcholinesterase inhibitor (AChEI) therapy for Alzheimer's disease.
Yang G; Wu J; Lei H; Hui Y
Int J Surg; 2024 May; ():. PubMed ID: 38728857
[No Abstract] [Full Text] [Related]
25. Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.
Grabrucker AM; Rowan M; Garner CC
Drug Deliv Lett; 2011 Sep; 1(1):13-23. PubMed ID: 22102982
[TBL] [Abstract][Full Text] [Related]
26. Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent Inflammation.
Rivers-Auty J; Tapia VS; White CS; Daniels MJD; Drinkall S; Kennedy PT; Spence HG; Yu S; Green JP; Hoyle C; Cook J; Bradley A; Mather AE; Peters R; Tzeng TC; Gordon MJ; Beattie JH; Brough D; Lawrence CB
J Neurosci; 2021 Mar; 41(13):3025-3038. PubMed ID: 33597269
[TBL] [Abstract][Full Text] [Related]
27. Most Effective Combination of Nutraceuticals for Improved Memory and Cognitive Performance in the House Cricket,
Madireddy S; Madireddy S
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33504066
[TBL] [Abstract][Full Text] [Related]
28. The Function and Regulation of Zinc in the Brain.
Krall RF; Tzounopoulos T; Aizenman E
Neuroscience; 2021 Mar; 457():235-258. PubMed ID: 33460731
[TBL] [Abstract][Full Text] [Related]
29. Brain volumetric deficits in MAPT mutation carriers: a multisite study.
Chu SA; Flagan TM; Staffaroni AM; Jiskoot LC; Deng J; Spina S; Zhang L; Sturm VE; Yokoyama JS; Seeley WW; Papma JM; Geschwind DH; Rosen HJ; Boeve BF; Boxer AL; Heuer HW; Forsberg LK; Brushaber DE; Grossman M; Coppola G; Dickerson BC; Bordelon YM; Faber K; Feldman HH; Fields JA; Fong JC; Foroud T; Gavrilova RH; Ghoshal N; Graff-Radford NR; Hsiung GR; Huey ED; Irwin DJ; Kantarci K; Kaufer DI; Karydas AM; Knopman DS; Kornak J; Kramer JH; Kukull WA; Lapid MI; Litvan I; Mackenzie IRA; Mendez MF; Miller BL; Onyike CU; Pantelyat AY; Rademakers R; Marisa Ramos E; Roberson ED; Carmela Tartaglia M; Tatton NA; Toga AW; Vetor A; Weintraub S; Wong B; Wszolek ZK; ; Van Swieten JC; Lee SE
Ann Clin Transl Neurol; 2021 Jan; 8(1):95-110. PubMed ID: 33247623
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanism of zinc neurotoxicity in Alzheimer's disease.
Narayanan SE; Rehuman NA; Harilal S; Vincent A; Rajamma RG; Behl T; Uddin MS; Ashraf GM; Mathew B
Environ Sci Pollut Res Int; 2020 Dec; 27(35):43542-43552. PubMed ID: 32909132
[TBL] [Abstract][Full Text] [Related]
31. Iron Metabolism in the Peripheral Nervous System: The Role of DMT1, Ferritin, and Transferrin Receptor in Schwann Cell Maturation and Myelination.
Santiago González DA; Cheli VT; Wan R; Paez PM
J Neurosci; 2019 Dec; 39(50):9940-9953. PubMed ID: 31676601
[TBL] [Abstract][Full Text] [Related]
32. Pentoxifylline as Add-On Treatment to Donepezil in Copper Sulphate-Induced Alzheimer's Disease-Like Neurodegeneration in Rats.
Elseweidy MM; Mahrous M; Ali SI; Shaheen MA; Younis NN
Neurotox Res; 2023 Dec; 41(6):546-558. PubMed ID: 37821782
[TBL] [Abstract][Full Text] [Related]
33. Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022.
Scolari Grotto F; Glaser V
Biometals; 2024 Feb; 37(1):3-22. PubMed ID: 37594582
[TBL] [Abstract][Full Text] [Related]
34. Metals in Alzheimer's Disease.
Babić Leko M; Langer Horvat L; Španić Popovački E; Zubčić K; Hof PR; Šimić G
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189779
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms.
Ma Y; Li Y; Yin R; Guo P; Lei N; Li G; Xiong L; Xie Y
CNS Neurosci Ther; 2023 Aug; 29(8):2045-2059. PubMed ID: 37122144
[TBL] [Abstract][Full Text] [Related]
36. Ameliorative effects of zinc supplementation on cognitive function and hippocampal leptin signaling pathway in obese male and female rats.
Hafez LM; Aboudeya HM; Matar NA; El-Sebeay AS; Nomair AM; El-Hamshary SA; Nomeir HM; Ibrahim FAR
Sci Rep; 2023 Mar; 13(1):5072. PubMed ID: 36977735
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of
Hosseini MJ; Mahmoodi N; Eskandari J; Bijani S; Yazdinezhad AR; Anoush M
Heliyon; 2022 Apr; 8(4):e09295. PubMed ID: 35520614
[TBL] [Abstract][Full Text] [Related]
38. Esculetin and Fucoidan Attenuate Autophagy and Apoptosis Induced by Zinc Oxide Nanoparticles through Modulating Reactive Astrocyte and Proinflammatory Cytokines in the Rat Brain.
Song WJ; Kim J; Shin T; Jeong MS; Kim KN; Yun JH; Wie MB
Toxics; 2022 Apr; 10(4):. PubMed ID: 35448455
[TBL] [Abstract][Full Text] [Related]
39. The next step of neurogenesis in the context of Alzheimer's disease.
Moradi HR; Hajali V; Khaksar Z; Vafaee F; Forouzanfar F; Negah SS
Mol Biol Rep; 2021 Jul; 48(7):5647-5660. PubMed ID: 34232464
[TBL] [Abstract][Full Text] [Related]
40. Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating
Squitti R; Ventriglia M; Simonelli I; Bonvicini C; Costa A; Perini G; Binetti G; Benussi L; Ghidoni R; Koch G; Borroni B; Albanese A; Sensi SL; Rongioletti M
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
